NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

30.56

+0.16 (0.53%)

At close: Jun 15, 2026, 4:00 PM EDT

30.60

+0.04 (0.13%)

After-hours: Jun 15, 2026, 4:11 PM EDT

NAMS Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	22.57	22.5	45.56	14.09	102.69	-
Revenue Growth (YoY)	-52.13%	-50.61%	223.37%	-86.28%	-	-
Gross Profit	22.57	22.5	45.56	14.09	102.69	-
Selling, General & Admin	102.65	-110.99	-73.22	37.63	-22.91	-5.46
Research & Development	135.09	-138.89	-152.78	159.42	-88.46	-28.47
Other Operating Expenses	-	-	-	-	62.26	-
Total Operating Expenses	237.74	-249.88	-226	197.06	-49.11	-33.93
Operating Income	-216.87	-227.37	-180.44	-182.97	-70.94	-33.93
Interest Income	25.89	27.59	16.88	11.28	0.01	0.01
Interest Expense	-	-0.02	-0.03	-	-0.29	-0.25
Other Non-Operating Income (Expense)	15.68	-5.73	-82.19	-5.23	-10.79	1.64
Total Non-Operating Income (Expense)	41.57	21.84	-65.34	6.06	-11.06	1.41
Pretax Income	-214.45	-205.53	-245.78	-176.91	-82	-32.52
Provision for Income Taxes	-	-	0	0.03	-	-
Net Income	-214.45	-205.53	-245.78	-176.94	-82	-32.52
Net Income to Common	-48.44	-205.53	-245.78	-176.94	-82	-32.52
Shares Outstanding (Basic)	120	118	94	82	19	24
Shares Outstanding (Diluted)	120	118	94	82	19	24
Shares Change (YoY)	18.33%	25.50%	14.84%	333.20%	-19.76%	156.56%
EPS (Basic)	-1.81	-1.74	-2.60	-2.15	-1.19	-1.38
EPS (Diluted)	-1.81	-1.74	-2.60	-2.15	-1.19	-1.38
Free Cash Flow	-142.19	-143.26	-159.05	-141.24	7.02	-28.64
Free Cash Flow Per Share	-1.19	-1.21	-1.69	-1.72	0.37	-1.21
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-961.09%	-1010.42%	-396.02%	-1298.56%	-69.08%	-
Profit Margin	-950.36%	-913.36%	-539.42%	-1255.76%	-79.85%	-
FCF Margin	-630.12%	-636.63%	-349.08%	-1002.43%	6.83%	-
EBITDA	-216.64	-227.04	-180.21	-182.92	-70.86	-33.91
EBITDA Margin	-960.07%	-1008.92%	-395.51%	-1298.21%	-69.00%	-
EBIT	-216.87	-227.37	-180.44	-182.97	-70.94	-33.93
EBIT Margin	-961.09%	-1010.42%	-396.02%	-1298.56%	-69.08%	-
Effective Tax Rate	-	0.00%	-0.00%	-0.02%	0.00%	0.00%

SEC Filings: 10-K · 10-Q